Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2016

01-11-2016 | Research Letter

Effectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failure

Authors: N. C. Chilelli, D. Cremasco, C. Cosma, E. Ragazzi, F. Francini Pesenti, L. Bonfante, A. Lapolla

Published in: Endocrine | Issue 2/2016

Login to get access

Excerpt

To the Editor, …
Literature
1.
T. Neade, J. Uribarri, Diet, inflammation, and chronic kidney disease: getting to the heart of the matter. Semin. Dial. 21, 331–337 (2008)CrossRefPubMed
2.
S. Yamagishi, T. Matsui, Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid. Med. Cell Longev. 3, 101e8 (2010)CrossRef
3.
N.C. Chilelli, S. Burlina, A. Lapolla, AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a “glycoxidation-centric” point of view. Nutr. Metab. Cardiovasc. Dis. 23, 913–919 (2013)CrossRefPubMed
4.
A. Lapolla, R. Reitano, R. Seraglia, G. Sartore, E. Ragazzi, P. Traldi, Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress. Mol. Nutr. Food Res. 49, 685–690 (2005)CrossRefPubMed
5.
K. Kanková, Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent? Proc. Nutr. Soc. 67, 60e74 (2008)CrossRef
6.
N.J. Kellow, G.S. Savige, Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. Eur. J. Clin. Nutr. 67, 239–248 (2013)CrossRefPubMed
7.
8.
J. Meng, N. Sakata, Y. Imanaga, Y. Tachikawa, J. Chihara, S. Takebayashi, Evidence for a link between glycoxidation and lipoperoxidation in patients with chronic renal failure. Clin. Nephrol. 51, 280–289 (1999)PubMed
9.
J. Uribarri, S. Woodruff, S. Goodman, W. Cai, X. Chen, R. Pyzik, A. Yong, G.E. Striker, H. Vlassara, Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Diet. Assoc. 110, 911–916 (2010)CrossRefPubMedPubMedCentral
10.
F.E. Thompson, A.F. Subar, Dietary assessmentmethodology, in Nutrition in the Prevention and Treatment of Disease, ed. by A.M. Coulston, C.J. Broushey (Academic Press, Philadelphia, 2008), pp. 3–39
11.
F. Piarulli, A. Lapolla, G. Sartore, C. Rossetti, G. Bax, M. Noale, N. Minicuci, C. Fiore, L. Marchioro, E. Manzato, D. Fedele, Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes. Diabetes Care 28, 653–657 (2005)CrossRefPubMed
12.
F. Piarulli, A. Lapolla, E. Ragazzi et al., Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients. Atherosclerosis 226, 252–257 (2013)CrossRefPubMed
13.
K. Sebeková, M. Krajcoviová-Kudlácková, R. Schinzel et al., Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet. Eur. J. Nutr. 40, 275–281 (2001)CrossRefPubMed
14.
A. Gugliucci, K. Kotani, J. Taing et al., Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults. Ann. Nutr. Metab. 54, 197–201 (2009)CrossRefPubMed
15.
J. Uribarri, M. Peppa, W. Cai, T. Goldberg, M. Lu, C. He, H. Vlassara, Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J. Am. Soc. Nephrol. 14, 728–731 (2003)CrossRefPubMed
16.
M. Peppa, J. Uribarri, W. Cai, M. Lu, H. Vlassara, Glycoxidation and inflammation in renal failure patients. Am. J. Kidney Dis. 43, 690–695 (2005)CrossRef
17.
A.L. Catapano, Z. Reiner, G. De Backer et al., ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 217, S1–S44 (2011)PubMed
18.
L. De Nicola, M. Provenzano, P. Chiodini et al., SIR-SIN study group: prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy. Nutr. Metab. Cardiovasc. Dis. 25, 756–762 (2015)CrossRefPubMed
19.
N.D. Vaziri, K.C. Norris, Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations. Blood Purif. 35, 31–36 (2013)CrossRefPubMedPubMedCentral
Metadata
Title
Effectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failure
Authors
N. C. Chilelli
D. Cremasco
C. Cosma
E. Ragazzi
F. Francini Pesenti
L. Bonfante
A. Lapolla
Publication date
01-11-2016
Publisher
Springer US
Published in
Endocrine / Issue 2/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0805-5

Other articles of this Issue 2/2016

Endocrine 2/2016 Go to the issue

Meta-Analysis

Sexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the Female Sexual Function Index

Original Article

Physical exam in asymptomatic people drivers the detection of thyroid nodules undergoing ultrasound guided fine needle aspiration biopsy

Original Article

Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients

Original Article

Growth development in children with congenital hypothyroidism: the effect of screening and treatment variables—a comprehensive longitudinal study

Mini Review

Estrogens and selective estrogen receptor modulators in acromegaly

Original Article

SF-1 deficiency causes lipid accumulation in Leydig cells via suppression of STAR and CYP11A1
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits